Single Doses of Antibody Drug Conjugates (ADCs) Targeted to CD117 or CD45 Have Potent in Vivo Anti-Leukemia Activity and Survival Benefit in Patient Derived AML Models
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2018.12.369
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2019
Authors
Publisher
Elsevier BV